As Anthropic eyes a mega-IPO, why are Chinese tech valuations so far behind?




Originally published by Pacific Forum, this article is republished with permission. A central problem in US nuclear thinking is that it is fragmented. Washington is laser-focused on the “three-body problem”: It considers the US-Russia-China triangle fundamental, and when it does not ignore the China-India-Pakistan triangle, it treats it as a mere “Southern Asia” issue. Washington, […]
The post The rise of the nuclear hexagon and the future of Asian stability appeared first on Asia Times.






Beijing has vowed to defend its firms after Washington blocked imports from China’s leading genomics group, extending the two countries’ trade war into biotechnology weeks before their leaders are due to meet in Shenzhen. The US Department of Homeland Security (DHS) on Wednesday added three Shenzhen-based companies to the Uyghur Forced Labor Prevention Act (UFLPA) […]
The post Pre-APEC US ban on Chinese genomic giant widens biotech decoupling appeared first on Asia Times.


Samsung Electronics reported the most profitable quarter in its history on Thursday, with operating profit of 107.4 trillion won on revenue of 195.3 trillion won, and still watched its shares close more than 4% lower. At one point they were down 6.6%. The KOSPI, which had broken above 6,000 the day before, slipped back under […]
The post Why Samsung’s record profits weren’t enough for investors appeared first on Asia Times.








Recent reports indicate that North Korean leader Kim Jong Un attempted to visit China to orchestrate a dramatic diplomatic scene akin to his June 2019 summit with US President Donald Trump at Panmunjom – but Beijing politely turned him down. Kim’s primary motive for seeking a visit to China stemmed from mounting frustration with Russian […]
The post Beijing gave Kim Jong Un the cold shoulder and here’s why appeared first on Asia Times.
